IrisVision

IrisVision designs and builds wearable devices that enable visually impaired individuals to see more clearly and maintain their independence. Founded in 2017 by Ammad Khan, the company collaborates with experts at Johns Hopkins and is backed by the National Institutes of Health. IrisVision's mission is to integrate vision health solutions into daily living, making them accessible to people worldwide.

The company offers FDA-registered, Class I medical devices that combine cutting-edge technology with custom software. These devices are particularly effective for individuals with conditions such as Macular Degeneration, Diabetic Retinopathy, and Retinitis Pigmentosa. IrisVision also provides personalized coaching and support, ensuring users can maximize the benefits of their devices from the comfort of their homes.

IrisVision has helped thousands of people improve their quality of life by enabling them to perform daily activities and enjoy the visual world around them. The company continues to innovate at the intersection of digital health and vision science, aiming to prevent vision loss and expand access to care for those at high risk.